Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 7/20 | 0.46 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.43 |
| ▸ | ANPEP | P15144 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.40 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.40 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.40 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.38 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.37 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mercaptopropionic Acid SCHEMBL14829321 | 1.00 | ACE (0.50) | ACEFOLH1ENPEPANPEPLMNA | |
| Mercaptopropionic Acid SCHEMBL330873 | 1.00 | ACE (0.50) | ACEFOLH1ENPEPANPEPLMNA | |
| Mercaptopropionic Acid SCHEMBL330800 | 1.00 | ACE (0.50) | ACEFOLH1ENPEPANPEPLMNA | |
| Mercaptopropionic Acid SCHEMBL331658 | 1.00 | ACE (0.50) | ACEFOLH1ENPEPANPEPLMNA | |
| Mercaptopropionic Acid SCHEMBL331852 | 1.00 | ACE (0.50) | ACEFOLH1ENPEPANPEPLMNA | |
| Mercaptopropionic Acid SCHEMBL996885 | 1.00 | ACE (0.50) | ACEFOLH1ENPEPANPEPLMNA | |
| Mercaptopropionic Acid SCHEMBL863468 | 1.00 | ACE (0.50) | ACEFOLH1ENPEPANPEPLMNA | |
| Mercaptopropionic Acid SCHEMBL99518 | 1.00 | ACE (0.50) | ACEFOLH1ENPEPANPEPLMNA | |
| Mercaptopropionic Acid SCHEMBL56209 | 1.00 | ACE (0.50) | ACEFOLH1ENPEPANPEPLMNA | |
| Mercaptopropionic Acid SCHEMBL574355 | 0.95 | ACE (0.46) | ACEFOLH1ENPEPANPEPLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2325231-B1 | MULTIBRANCHED POLYALKYLENE GLYCOL POLYMER AND MANUFACTURING METHOD THEREOF, AND CEMENT ADMIXTURE | NIPPON CATALYTIC CHEM IND (JP) | 2019-11-06 | — | — | EP | disclosed |
| US-8476341-B2 | Multi-branched polyalkylene glycol polymer, method for producing the same, and admixture for cement | NIPPON SHOKUBAI CO., LTD. (JP) | 2013-07-02 | — | — | US | disclosed |
| US-20110160393-A1 | MULTI-BRANCHED POLYALKYLENE GLYCOL POLYMER, METHOD FOR PRODUCING THE SAME, AND ADMIXTURE FOR CEMENT | NIPPON SHOKUBAI CO., LTD. (JP) | 2011-06-30 | — | — | US | disclosed |
| EP-2325231-A1 | MULTIBRANCHED POLYALKYLENE GLYCOL POLYMER AND MANUFACTURING METHOD THEREOF, AND CEMENT ADMIXTURE | Nippon Shokubai Co., Ltd. (JP) | 2011-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110160393-A1 | MULTI-BRANCHED POLYALKYLENE GLYCOL POLYMER, METHOD FOR PRODUCING THE SAME, AND ADMIXTURE FOR CEMENT | VCL, XRCC5, BCR | ACE 3682/4885FOLH1 2049/4885ENPEP 1218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.